Samuel Youssef
National Institutes of Health
4 Papers
122 Citations
Samuel Youssef is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Transplantation & Progenitor cell. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Samuel Youssef include Imperial College London.
Chat about Author
Papers
Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
Gopal K. Soppa,Joon Ha Lee,Mark A. Stagg,Leanne E. Felkin,Paul J.R. Barton,Urszula Siedlecka,Samuel Youssef,Magdi H. Yacoub,Cesare M. Terracciano +8 more
TL;DR: Clenbuterol treatment of failing rat hearts, alone or in combination with mechanical unloading, improves LV function at the whole-heart and cellular levels by affecting cell morphology, excitation–contraction coupling, and myofilament sensitivity to calcium.
75
Prolonged mechanical unloading reduces myofilament sensitivity to calcium and sarcoplasmic reticulum calcium uptake leading to contractile dysfunction.
Gopal K. Soppa,Joon Ha Lee,Mark A. Stagg,Urszula Siedlecka,Samuel Youssef,Magdi H. Yacoub,Cesare M. Terracciano +6 more
TL;DR: Prolonged myocardial unloading causes depressed contractility due to reduced SR Ca( 2+) uptake and myofilament sensitivity to Ca(2+).
40
Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes
Joon Ha Lee,Mark A. Stagg,Satsuki Fukushima,Gopal K. Soppa,Urszula Siedlecka,Samuel Youssef,Ken Suzuki,Magdi H. Yacoub,Cesare M. Terracciano +8 more
TL;DR: The morphology, contractile performance, and excitation-contraction coupling of individual recipient cardiomyocytes are altered in failing hearts treated with adult progenitor cell transplantation.
19
Corrigendum to: Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure
Gopal K. Soppa,Joon Ha Lee,Mark A. Stagg,Leanne E. Felkin,Paul J.R. Barton,Urszula Siedlecka,Samuel Youssef,Magdi H. Yacoub,Cesare M. Terracciano +8 more
TL;DR: This data indicates that pre-existing coronary artery disease may be a major cause of death in women aged 45 and over, and the use of statins to correct for these problems is a natural application.